SKIP000270 | |
SKIP ID | SKIP000270 |
Organism(En) | - |
Organism(Ja) | - |
Cell Type(En) | - |
Cell Type(Ja) | - |
Cell Tissue(En) | - |
Cell Tissue(Ja) | - |
Cell Origin | Diseased |
Cell Name 1(En) | HPS0087 |
Cell Name 1(Ja) | HPS0087 |
Cell Name 2(En) | iOCT4 |
Cell Name 2(Ja) | iOCT4 |
Disease Name 1(Ja) | オルニチントランスカルバミナーゼ欠損症 |
ICD Code 1 | E724 |
Disease Name 1(En) | Ornithinetranscarbamylase deficiency |
OMIM1 | 311250 |
Disease Name 2(Ja) | - |
ICD Code 2 | - |
Disease Name 2(En) | - |
OMIM 2 | - |
Disease Name 3(Ja) | - |
ICD Code 3 | - |
Disease Name 3(En) | - |
OMIM 3 | - |
Age | - |
Age Range | -- |
Sex | -- |
Race(En) | Japanese |
Race(Ja) | Japanese |
Genetic Diagnosis | Yes |
Not Detected | No |
Description(En) | Disease specific iPS cell line derived from a patient: Ornithinetranscarbamylase deficiency (RCB0492 OTCD1TKB). |
Description(Ja) | 疾患特異的iPS細胞株。オルニチントランスカルバミナーゼ欠損症患者由来(RCB0492 OTCD1TKB)。センダイウイルスベクターにより4因子(Oct3/4, Sox2, Klf4, c-Myc)を導入。 |
Cell Morphology | human ES-like |
Grade | -- |
Vector | Sendai virus |
Transgene | SeV18+HS-OCT3/4/TS Delta F, SeV18+HS-SOX2/TS Delta F, SeV18+HS-KLF4/TS Delta F, SeV18(HNL)c-MYCQC/TS Delta F |
Adhesiveness | - |
Feeder | Yes |
Feeder Cell | MEF (X-rays:5000R or MMC) 3-5x10^(5) cells/60mm dish |
Medium | DMEM/HamF12(2mM L-Glutamine)+20%KSR+0.1mM NEAA+0.1mM 2-Mercaptoethanol+5ng/ml human bFGF |
Genome Editing | - |
CO2 | - |
Mycoplasma | - |
Detection of Contaminants Mycoplasma | - |
Pluripotent Markers | - |
Pluripotent Markers Assay | - |
in vitro Differentiation | - |
in vitro Differentiation Assay | - |
in vivo Differentiation | - |
in vivo Differentiation Assay | - |
Other 1 Assay | - |
Other 1 Assay Method | - |
Other 2 Assay | - |
Other 2 Assay Method | - |
Other 3 Assay | - |
Other 3 Assay Method | - |
Karyotype | - |
Karyotype Assay | - |
Remaining Vector Detection | - |
Remaining Vector Detection Assay | - |
STR | - |
HLA | - |
Stem Cell Transcriptome analysis | - |
Stem Cell Transcriptome analysis Assay | - |
Author Name(En) | - |
Author Name(Ja) | - |
Author Organization(En) | - |
Author Organization(Ja) | - |
Author Contact Email | - |
PI Organization(En) | Cell-Medicine, Inc. |
PI Organization(Ja) | セルメディシン株式会社 |
PI Name(En) | Dr.Ohno, Tadao |
PI Name(Ja) | 大野 忠夫 |
PI Contact Email | - |
Availability | Available |
Provider Organization(En) | RikenBRC |
Provider Organization(Ja) | 理研BRC |
Provider Email | cellbank[at]brc[dot]riken[dot]jp |
Provider URL | http://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=HPS0087&type=1 |
Ethical Statement(En) | - |
Ethical Statement(Ja) | - |
Terms of Use(En) | - |
Terms of Use(Ja) | - |
PubMed ID | - |
DOI | - |
Title | - |
Authors | - |
Journal | - |
Year | - |
Volume | - |
Issue | - |
Pages | - |
URL | - |
Free input | - |
Note | Parent Line:http://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=RCB0492&type=1 保存:DAP213 : Medium+2M DMSO+1M Acetamide+3M Propyleneglycol |